Application Note: Elevations of Cardiac Troponin‐I Quantified with the Erenna® cTnI Immunoassay are an Early Indicator of Heart Muscle Injury in Studies of Cardiotoxicity
30 March 2012

This application note describes the utility of the Erenna Immunoassay System and the Erenna cTnI Assay towards early assessment of cardiotoxicity in rats. Due to its unique high definition technology it is shown that elevated levels of cTnI in serum can be detected earlier with the Erenna Immunoassay System.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me

Company